ArticleLiver research (Beijing, China)2022

MUTYH is a potential prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma.

Fan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.